LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 87 filers reported holding LION BIOTECHNOLOGIES INC in Q2 2015. The put-call ratio across all filers is 2.05 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,523,000 | -14.7% | 219,108 | +0.9% | 0.00% | 0.0% |
| Q3 2016 | $1,786,000 | +24.7% | 217,061 | +22.8% | 0.00% | 0.0% |
| Q2 2016 | $1,432,000 | +76.4% | 176,831 | +10.6% | 0.00% | +100.0% |
| Q1 2016 | $812,000 | -32.9% | 159,856 | +2.0% | 0.00% | -50.0% |
| Q4 2015 | $1,210,000 | +35.3% | 156,720 | +0.9% | 0.00% | +100.0% |
| Q3 2015 | $894,000 | -38.6% | 155,273 | -2.1% | 0.00% | -50.0% |
| Q2 2015 | $1,455,000 | – | 158,645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 3,187,607 | $24,608,000 | 8.48% |
| ACUTA CAPITAL PARTNERS, LLC | 1,915,000 | $14,784,000 | 7.07% |
| P.A.W. CAPITAL CORP | 200,000 | $1,544,000 | 1.75% |
| Perceptive Advisors | 3,000,161 | $23,161,000 | 1.71% |
| NEXTHERA CAPITAL LP | 152,266 | $1,175,000 | 1.67% |
| Broadfin Capital, LLC | 2,105,519 | $16,255,000 | 1.00% |
| Trellus Management Company, LLC | 60,539 | $467,000 | 0.69% |
| Rhenman & Partners Asset Management AB | 575,000 | $4,439,000 | 0.67% |
| QVT Financial LP | 1,433,700 | $11,068,000 | 0.62% |
| Cormorant Asset Management, LP | 499,815 | $3,859,000 | 0.46% |